These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Late coronary stent thrombosis and clopidogrel]. Varvarovský I; Matejka J; Herman A Vnitr Lek; 2007 Oct; 53(10):1085-91. PubMed ID: 18072434 [TBL] [Abstract][Full Text] [Related]
12. [Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?]. Baralis G; Steffenino G; Dellavalle A; La Scala E; Uslenghi E Ital Heart J Suppl; 2003 Sep; 4(9):766-70. PubMed ID: 14635395 [TBL] [Abstract][Full Text] [Related]
13. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial. Di Lorenzo E; De Luca G; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G JACC Cardiovasc Interv; 2009 Jun; 2(6):515-23. PubMed ID: 19539255 [TBL] [Abstract][Full Text] [Related]
14. Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials. Caixeta A; Lansky AJ; Serruys PW; Hermiller JB; Ruygrok P; Onuma Y; Gordon P; Yaqub M; Miquel-Hebert K; Veldhof S; Sood P; Su X; Jonnavithula L; Sudhir K; Stone GW; JACC Cardiovasc Interv; 2010 Dec; 3(12):1220-8. PubMed ID: 21232715 [TBL] [Abstract][Full Text] [Related]
15. Premature discontinuation of antiplatelet therapy in patients with drug-eluting coronary stents. McAllister RK; Dehmer GJ; Meyer TA Am J Health Syst Pharm; 2006 Dec; 63(23):2308-10. PubMed ID: 17106000 [No Abstract] [Full Text] [Related]
16. Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study. Biondi-Zoccai GG; Agostoni P; Sangiorgi GM; Iakovou I; Antoniucci D; Grube E; Tamburino C; Di Mario C; Reimers B; Michev I; Goktekin O; Airoldi F; Chieffo A; Cosgrave J; Tassanawiwat W; Colombo A; Int J Cardiol; 2006 Apr; 108(3):406-7. PubMed ID: 16520130 [TBL] [Abstract][Full Text] [Related]
17. A paclitaxel-eluting stent for the prevention of coronary restenosis. Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373 [TBL] [Abstract][Full Text] [Related]
18. Stent thrombosis four and a half years after implantation of a sirolimus-eluting stent. Korovesis S; Katritsis DG Hellenic J Cardiol; 2009; 50(5):423-5. PubMed ID: 19767286 [TBL] [Abstract][Full Text] [Related]
19. The lack of endothelization after drug-eluting stent implantation as a cause of fatal late stent thrombosis. Jakabcin J; Bystron M; Spacek R; Veselka J; Kvasnak M; Kala P; Malý J; Cervinka P J Thromb Thrombolysis; 2008 Oct; 26(2):154-8. PubMed ID: 17764000 [TBL] [Abstract][Full Text] [Related]
20. Sirolimus-eluting stent thrombosis several years after clopidogrel discontinuation. Joyal D; Rudski L J Invasive Cardiol; 2007 Sep; 19(9):E265-7. PubMed ID: 17827517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]